Literature DB >> 20952682

A ligand for CD5 is CD5.

Marion H Brown1, Erica Lacey.   

Abstract

Recognition by scavenger receptor cysteine-rich domains on membrane proteins regulates innate and adaptive immune responses. Two receptors expressed primarily on T cells, CD5 and CD6, are linked genetically and are structurally similar, both containing three scavenger receptor cysteine-rich domains in their extracellular regions. A specific cell surface interaction for CD5 has been difficult to define at the molecular level because of the susceptibility of CD5 protein to denaturation. By using soluble CD5 purified at neutral pH to preserve biological activity, we show that CD5 mediates species-specific homophilic interactions. CD5 domain 1 only is involved in the interaction. CD5 mAbs that have functional effects in humans, rats, and mice block homophilic binding. Ag-specific responses by mouse T cells in vitro were increased when engagement of human CD5 domain 1 was inhibited by mutation or by IgG or Fab fragment from a CD5 mAb. This showed that homophilic binding results in productive engagement. Enhancement of polyclonal immune responses of rat lymph node cells by a Fab fragment from a CD5 mAb shown to block homophilic interactions provided evidence that the extracellular region of CD5 regulates inhibition in normal cells. These biochemical and in vitro functional assays provide evidence that the extracellular region of CD5 regulates immunity through species-specific homophilic interactions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20952682      PMCID: PMC2996635          DOI: 10.4049/jimmunol.0903823

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  Negative regulation of CD4 lineage development and responses by CD5.

Authors:  C Peña-Rossi; L A Zuckerman; J Strong; J Kwan; W Ferris; S Chan; A Tarakhovsky; A D Beyers; N Killeen
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

2.  CD2 physically associates with CD5 in rat T lymphocytes with the involvement of both extracellular and intracellular domains.

Authors:  Mónica A A Castro; Paula A Tavares; Mara S Almeida; Raquel J Nunes; Mark D Wright; Don Mason; Alexandra Moreira; Alexandre M Carmo
Journal:  Eur J Immunol       Date:  2002-05       Impact factor: 5.532

3.  Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells.

Authors:  Aukje W Zimmerman; Ben Joosten; Ruurd Torensma; Jane R Parnes; Frank N van Leeuwen; Carl G Figdor
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

4.  Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody.

Authors:  Ruby Alonso; Vivian Huerta; Joel de Leon; Patricia Piedra; Yaquelin Puchades; Osmany Guirola; Glay Chinea; Enrique Montero
Journal:  Hybridoma (Larchmt)       Date:  2008-08

5.  A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5.

Authors:  G Bikah; F M Lynd; A A Aruffo; J A Ledbetter; S Bondada
Journal:  Int Immunol       Date:  1998-08       Impact factor: 4.823

6.  Extracellular isoforms of CD6 generated by alternative splicing regulate targeting of CD6 to the immunological synapse.

Authors:  Mónica A A Castro; Marta I Oliveira; Raquel J Nunes; Stéphanie Fabre; Rita Barbosa; António Peixoto; Marion H Brown; Jane R Parnes; Georges Bismuth; Alexandra Moreira; Benedita Rocha; Alexandre M Carmo
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

7.  The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome.

Authors:  Jorge Vera; Rafael Fenutría; Olga Cañadas; Maite Figueras; Rubén Mota; Maria-Rosa Sarrias; David L Williams; Cristina Casals; José Yelamos; Francisco Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-13       Impact factor: 11.205

8.  CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76.

Authors:  Namir J Hassan; Stephen J Simmonds; Nicholas G Clarkson; Sarah Hanrahan; Michael J Puklavec; Martine Bomb; A Neil Barclay; Marion H Brown
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

9.  2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48.

Authors:  M H Brown; K Boles; P A van der Merwe; V Kumar; P A Mathew; A N Barclay
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

10.  CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity.

Authors:  H S Azzam; A Grinberg; K Lui; H Shen; E W Shores; P E Love
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

View more
  26 in total

1.  Distinct CD4+ helper T cells involved in primary and secondary responses to infection.

Authors:  K Scott Weber; Qi-Jing Li; Stephen P Persaud; Jeff D Campbell; Mark M Davis; Paul M Allen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

Review 2.  Searching for "signal 2": costimulation requirements of γδ T cells.

Authors:  Julie C Ribot; Ana debarros; Bruno Silva-Santos
Journal:  Cell Mol Life Sci       Date:  2011-05-04       Impact factor: 9.261

Review 3.  The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease.

Authors:  Gloria Soldevila; Chander Raman; Francisco Lozano
Journal:  Curr Opin Immunol       Date:  2011-04-07       Impact factor: 7.486

4.  Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 Complex.

Authors:  Uri Rozovski; David M Harris; Ping Li; Zhiming Liu; Preetesh Jain; Ivo Veletic; Alessandra Ferrajoli; Jan Burger; Susan O'Brien; Prithviraj Bose; Philip Thompson; Nitin Jain; William Wierda; Michael J Keating; Zeev Estrov
Journal:  Mol Cancer Res       Date:  2017-01-27       Impact factor: 5.852

5.  A type of human skin dendritic cell marked by CD5 is associated with the development of inflammatory skin disease.

Authors:  Daniel Korenfeld; Laurent Gorvel; Adiel Munk; Joshua Man; Andras Schaffer; Thomas Tung; Caroline Mann; Eynav Klechevsky
Journal:  JCI Insight       Date:  2017-09-21

6.  Locally Secreted Semaphorin 4D Is Engaged in Both Pathogenic Bone Resorption and Retarded Bone Regeneration in a Ligature-Induced Mouse Model of Periodontitis.

Authors:  Takenobu Ishii; Montserrat Ruiz-Torruella; Kenta Yamamoto; Tsuguno Yamaguchi; Alireza Heidari; Roodelyne Pierrelus; Elizabeth Leon; Satoru Shindo; Mohamad Rawas-Qalaji; Maria Rita Pastore; Atsushi Ikeda; Shin Nakamura; Hani Mawardi; Umadevi Kandalam; Patrick Hardigan; Lukasz Witek; Paulo G Coelho; Toshihisa Kawai
Journal:  Int J Mol Sci       Date:  2022-05-18       Impact factor: 6.208

7.  CD5-dependent CK2 activation pathway regulates threshold for T cell anergy.

Authors:  Christine M Sestero; Donald J McGuire; Patrizia De Sarno; Emily C Brantley; Gloria Soldevila; Robert C Axtell; Chander Raman
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

8.  A new pathway of CD5 glycoprotein-mediated T cell inhibition dependent on inhibitory phosphorylation of Fyn kinase.

Authors:  Martina Bamberger; Ana Mafalda Santos; Carine M Gonçalves; Marta I Oliveira; John R James; Alexandra Moreira; Franscisco Lozano; Simon J Davis; Alexandre M Carmo
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

9.  Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations.

Authors:  Domenico Maisano; Enrico Iaccino; Alessandro D'Ambrosio; Federico Chiurazzi; Vincenzo Dattilo; Mariangela Scalise; Massimo Gentile; Eleonora Vecchio; Nancy Nisticò; Annamaria Aloisio; Erika De Sensi; Giuseppe Fiume; Ileana Quinto; Selena Mimmi
Journal:  Front Oncol       Date:  2021-06-18       Impact factor: 6.244

10.  T-cell modulatory properties of CD5 and its role in antitumor immune responses.

Authors:  Mouna Tabbekh; M'barka Mokrani-Hammani; Georges Bismuth; Fathia Mami-Chouaib
Journal:  Oncoimmunology       Date:  2013-01-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.